603676 Stock Overview
Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Tibet Weixinkang Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.54 |
| 52 Week High | CN¥14.35 |
| 52 Week Low | CN¥6.30 |
| Beta | 0.063 |
| 1 Month Change | -9.34% |
| 3 Month Change | 0.35% |
| 1 Year Change | -35.50% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603676 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.2% | -1.1% | 0.06% |
| 1Y | -35.5% | -12.5% | -16.1% |
Return vs Industry: 603676 underperformed the CN Pharmaceuticals industry which returned -12.5% over the past year.
Return vs Market: 603676 underperformed the CN Market which returned -16.1% over the past year.
Price Volatility
| 603676 volatility | |
|---|---|
| 603676 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 603676 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603676's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 701 | Yong Zhang | www.wxkpharma.com |
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases, and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd.
Tibet Weixinkang Medicine Co., Ltd. Fundamentals Summary
| 603676 fundamental statistics | |
|---|---|
| Market cap | CN¥3.72b |
| Earnings (TTM) | CN¥248.69m |
| Revenue (TTM) | CN¥1.29b |
14.9x
P/E Ratio2.9x
P/S RatioIs 603676 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603676 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.29b |
| Cost of Revenue | CN¥621.92m |
| Gross Profit | CN¥668.19m |
| Other Expenses | CN¥419.51m |
| Earnings | CN¥248.69m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.57 |
| Gross Margin | 51.79% |
| Net Profit Margin | 19.28% |
| Debt/Equity Ratio | 0% |
How did 603676 perform over the long term?
See historical performance and comparison